30
Participants
Start Date
July 25, 2011
Primary Completion Date
August 30, 2011
Study Completion Date
August 30, 2011
Ciprofloxacin XR + MMX Placebo
MMX Mesalazine/mesalamine placebo dosed once-a-day (QD) orally for 3 days, then a single oral 500 mg dose of ciprofloxacin XR + a single oral dose of MMX Mesalazine/mesalamine placebo on day 4
MMX Mesalazine/mesalamine + Ciprofloxacin XR
MMX Mesalazine/mesalamine 4.8 g QD orally for 3 days, then a single oral 500 mg dose of ciprofloxacin XR + a single oral dose 4.8 g of MMX Mesalazine/mesalamine on day 4
PRA International, Lenexa
Lead Sponsor
Shire
INDUSTRY